General Dynamics a Top Ranked SAFE Dividend Stock With 2.2% Yield (GD)

General Dynamics Corp. (GD) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.2% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent ''DividendRank'' report.

According to the ETF Finder at ETF Channel, General Dynamics Corp. is a member of the iShares S&P 1500 Index ETF (ITOT), and is also an underlying holding representing 1.28% of the SPDR S&P Dividend ETF (SDY), which holds $155,595,804 worth of GD shares.

General Dynamics Corp. ( GD) made the "Dividend Channel S.A.F.E. 25" list because of these qualities: S. Solid return — hefty yield and strong DividendRank characteristics; A. Accelerating amount — consistent dividend increases over time; F. Flawless history — never a missed or lowered dividend; E. Enduring — at least two decades of dividend payments.

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades »

The annualized dividend paid by General Dynamics Corp. is $2.24/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 01/15/2014. Below is a long-term dividend history chart for GD, which the report stressed as being of key importance.

GD+Dividend+History+Chart

GD operates in the Aerospace & Defense sector, among companies like United Technologies Corp. (UTX), and Boeing Co. (BA).

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says